Depressive Relapse After Vagal Nerve Stimulator Explantation

被引：3

作者：

Ashton, Adam Keller ^{[1
,2
,3
,4
]}

机构：

[1] Bristol Myers Squibb Co, New York, NY 10154 USA

[2] Eli Lilly, Baltimore, MD USA

[3] GlaxoSmithKline Inc, London, England

[4] Merck, Whitehouse Stn, NJ USA

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2010年 / 167卷 / 06期

关键词：

PATIENT;

D O I：

10.1176/appi.ajp.2010.10010020

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：719 / 720

页数：5

相关论文

共 3 条

[1] Vagus nerve stimulation for depression: a case of a broken lead, depression relapse, revision surgery, and restoration of patient response
Conway, Charles R.
Chibnall, John T.
Tait, Raymond C.
[J]. BRAIN STIMULATION, 2008, 1 (03) : 227 - 228
[2] Vagus nerve stimulation therapy in a patient with treatment-resistant depression: A case report of long-term follow-up and battery end-of-service
Martinez, JM
Zboyan, HA
[J]. CNS SPECTRUMS, 2006, 11 (02) : 143 - 147
[3] Vocal Cord Dysfunction Arising From Vagal Nerve Stimulator Removal
Srinivasan, Shiva Prakash
Hall, Jonathan M.
Leo, Raphael J.
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (12) : 1412 - 1413